Versant Venture Capital VI, L.P. - 09 Apr 2024 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role: 10%+ Owner
Signature: Versant Vantage I, L.P. By: Versant Vantage I GP, L.P. Its: General Partner By: Versant Vantage I GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
Issuer symbol: CTNM
Transactions as of: 09 Apr 2024
Net transactions value: $0
Form type: 4
Filing time: 11 Apr 2024, 18:10:57 UTC
Previous filing: 04 Apr 2024
Next filing: 12 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTNM	Class A Common Stock	Conversion of derivative security		+391,785			391,785	09 Apr 2024	See footnote	F1, F2
transaction	CTNM	Class A Common Stock	Conversion of derivative security		+2,531			2,531	09 Apr 2024	See footnote	F1, F3
transaction	CTNM	Class A Common Stock	Conversion of derivative security		+148,312			148,312	09 Apr 2024	See footnote	F1, F4
holding	CTNM	Class A Common Stock						375,535	09 Apr 2024	Direct	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTNM	Series A Preferred Stock	Conversion of derivative security		+298,975			0	09 Apr 2024	Class A Common Stock	298,975		See footnote	F1, F2
transaction	CTNM	Series A Preferred Stock	Conversion of derivative security		+1,931			0	09 Apr 2024	Class A Common Stock	1,931		See footnote	F1, F3
transaction	CTNM	Series B Preferred Stock	Conversion of derivative security		+70,498			0	09 Apr 2024	Class A Common Stock	70,498		See footnote	F1, F2
transaction	CTNM	Series B Preferred Stock	Conversion of derivative security		+455			0	09 Apr 2024	Class A Common Stock	455		See footnote	F1, F3
transaction	CTNM	Series B Preferred Stock	Conversion of derivative security		+90,747			0	09 Apr 2024	Class A Common Stock	90,747		See footnote	F1, F4
transaction	CTNM	Series C Preferred Stock	Conversion of derivative security		+22,312			0	09 Apr 2024	Class A Common Stock	22,312		See footnote	F1, F2
transaction	CTNM	Series C Preferred Stock	Conversion of derivative security		+145			0	09 Apr 2024	Class A Common Stock	145		See footnote	F1, F3
transaction	CTNM	Series C Preferred Stock	Conversion of derivative security		+57,565			0	09 Apr 2024	Class A Common Stock	57,565		See footnote	F1, F4
transaction	CTNM	Series A Preferred Stock	Conversion of derivative security		+1,476,446			1,476,446	09 Apr 2024	Class B Common Stock	1,476,446		See footnote	F2, F6, F7
transaction	CTNM	Series A Preferred Stock	Conversion of derivative security		+9,252			9,252	09 Apr 2024	Class B Common Stock	9,252		See footnote	F3, F6, F7
transaction	CTNM	Series A-1 Preferred Stock	Conversion of derivative security		+1,423,119			1,423,119	09 Apr 2024	Class B Common Stock	1,423,119		Direct	F5, F6, F7
transaction	CTNM	Series B Preferred Stock	Conversion of derivative security		+348,143	+24%		1,824,589	09 Apr 2024	Class B Common Stock	348,143		See footnote	F2, F6, F7
transaction	CTNM	Series B Preferred Stock	Conversion of derivative security		+2,182	+24%		11,434	09 Apr 2024	Class B Common Stock	2,182		See footnote	F3, F6, F7
transaction	CTNM	Series B Preferred Stock	Conversion of derivative security		+434,725			434,725	09 Apr 2024	Class B Common Stock	434,725		See footnote	F4, F6, F7
transaction	CTNM	Series B Preferred Stock	Conversion of derivative security		+317,988	+22%		1,741,107	09 Apr 2024	Class B Common Stock	317,988		Direct	F5, F6, F7
transaction	CTNM	Series C Preferred Stock	Conversion of derivative security		+110,187	+6%		1,934,776	09 Apr 2024	Class B Common Stock	110,187		See footnote	F2, F6, F7
transaction	CTNM	Series C Preferred Stock	Conversion of derivative security		+689	+6%		12,123	09 Apr 2024	Class B Common Stock	689		See footnote	F3, F6, F7
transaction	CTNM	Series C Preferred Stock	Conversion of derivative security		+275,769	+63%		710,494	09 Apr 2024	Class B Common Stock	275,769		See footnote	F4, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Versant Venture Capital VI, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Upon the closing of the Issuer's initial public offering (the "IPO"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the "Preferred Stock") converted automatically into shares of the Issuer's Class A common stock (the "Class A Common Stock"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date.
F2	The shares are held directly by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV GP") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein.
F3	The shares are held directly by Versant Side Fund IV, L.P. ("VSF IV"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein.
F4	The shares are held directly by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP, L.P. ("VV I GP") is the general partner of VV I, and Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein.
F5	The shares are held directly by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP, L.P. ("VV VI GP") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC ("VV VI GP-GP") is the general partner of VV VI GP. Each of VV VI GP-GP and VV VI GP disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein.
F6	In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the "Class B Common Stock"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date.
F7	Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer.